One half-century of advances in the evaluation and management of disorders of bone and mineral metabolism in children and adolescents

J Pediatr Endocrinol Metab. 2023 Jan 13;36(2):105-118. doi: 10.1515/jpem-2022-0624. Print 2023 Feb 23.

Abstract

The past 50 years of research in pediatric bone and mineral metabolism have led to remarkable progress in the identification and characterization of disorders that affect the developing skeleton. Progress has been facilitated through advances in both technology and biology and this paper provides a brief description of some but not all of the key findings, including identification of the calcium sensing receptor and the polypeptides parathyroid hormone and parathyroid hormone-related protein as well as their shared receptor and signal generating pathways; the elucidation of vitamin D metabolism and actions; discovery of fibroblast growth factor 23 (FGF23), the sodium-phosphate co-transporters and the other components that regulate phosphate metabolism. Moreover, the past half-century of research has led to the delineation of the molecular bases for genetic forms of hypoparathyroidism, pseudohypoparathyroidism, and primary hyperparathyroidism as well as the determination of the genetic causes of osteogenesis imperfecta, osteopetrosis, hypophosphatasia, and other disorders of mineral/bone homeostasis. During the next decade we expect that many of these fundamental discoveries will lead to the development of innovative treatments that will improve the lives of children with these disorders.

Keywords: bone; bone metabolism; calcium; mineral.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Bone and Bones / metabolism
  • Calcium
  • Child
  • Fibroblast Growth Factors / genetics
  • Humans
  • Hypophosphatasia*
  • Osteogenesis Imperfecta*
  • Parathyroid Hormone
  • Phosphates
  • Vitamin D / metabolism

Substances

  • Parathyroid Hormone
  • Phosphates
  • Fibroblast Growth Factors
  • Calcium
  • Vitamin D